AHAbolfazl Hosseinnataj

Abolfazl Hosseinnataj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abolfazl Hosseinnataj has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protact versus chlorhexidine mouthwash for reducing streptococcus mutans on orthodontic elastomeric ligatures: a double-blind randomized clinical trial

    by Hodis Ehsani, Ali Semnani, Hamid Reza Goli, Ali Jafari, Mohammadreza Tadayon, Abolfazl Hosseinnataj, Tahura Etezadi

  • Effects of Olanzapine on Chemotherapy‐Related Anxiety in Pediatric Cancer Patients: A Pilot Study

    by Zahra Sahraee, Mohammad Naderisorki, Monireh Ghazaeian, Samaneh Farnia, Abolfazl Hosseinnataj, Hossein Kasiri, Mohammadreza Rafati, Shaghayegh Mohammadzadeh

    Background: Anxiety is prevalent in children with cancer and can impair treatment adherence, outcomes, and quality of life. Chemotherapy often increases anxiety, potentially worsening complications like nausea, vomiting, and poor cooperation. This study investigated the efficacy of olanzapine in mitigating chemotherapy‐induced anxiety in pediatric cancer patients. Methods: This pilot randomized, double‐blind, placebo‐controlled trial enrolled pediatric patients with cancer. Participants were randomly assigned to receive either olanzapine or placebo, with one daily dose administered from 2 days prior to 3 days following chemotherapy, totaling five doses. Anxiety was measured at baseline, on the day of chemotherapy, and at the end of treatment using the Spence Children's Anxiety Scale (SCAS) and Visual Analog Scale (VAS) for anxiety; nausea and vomiting were graded per Common Terminology Criteria for Adverse Events (CTCAE). Results: Between July 2024 and September 2025, 30 pediatric cancer patients (mean age 11.10 ± 2.59 years; 63% female) were enrolled and analyzed, with no significant demographic differences. SCAS scores showed a significant anxiety reduction in the olanzapine group post‐intervention ( p = 0.01) but not in the placebo group ( p = 0.428). VAS anxiety scores did not differ significantly between groups, though the overall 5‐day trend favored olanzapine. The olanzapine group also experienced improvements in nausea severity and vomiting frequency. Adverse effects were mild and transient. Conclusion: This pilot trial suggests that olanzapine may be both safe and effective in mitigating chemotherapy‐related anxiety in pediatric cancer patients. These findings indicate its potential as an adjunct to current anxiety‐management protocols. Further large‐scale, confirmatory studies with extended follow‐up are necessary to validate these results and evaluate long‐term outcomes.

  • Open Access

    Effect of Green‐Synthesized Silver Nanoparticles From Nepeta pogonosperma and Astrodaucus persicus on the Reduction of Bap Gene Expression in Strong Biofilm‐Producing Acinetobacter baumannii Clinical Isolates

    by Maedeh Kakavan, Mehrdad Gholami, Mohammad Ahanjan, Mohammad Ali Ebrahimzadeh, Abolfazl Hossein Nataj, Tahoora Mousavi, Hamid Reza Goli

    Given the critical role of the bap gene in biofilm formation of Acinetobacter baumannii , this study aimed to evaluate the efficacy of green‐synthesized silver nanoparticles (AgNPs) derived from Nepeta pogonosperma and Astrodaucus persicus (Boiss) in reducing the expression of this gene and inhibiting biofilm production in clinical isolates of A. baumannii . AgNPs were synthesized using the leaf extracts of the plants and characterized using standard techniques. The minimum inhibitory concentration of the AgNPs was determined by the microbroth dilution method. Biofilm production and the anti‐biofilm effects of the nanoparticles were assessed using a microtiter plate assay. Quantitative real‐time PCR was employed to evaluate bap gene expression levels before and after treatment with the AgNPs. The AgNPs significantly inhibited biofilm formation in A. baumannii . Furthermore, a marked reduction in bap gene expression was observed following treatment. Moreover, 90% and 10% of the isolates showed up to 60% and 61%–80% of biofilm disruption after treatment with A. persicus AgNP, respectively. In addition, 80%, 15%, and 5% of the isolates showed up to 60%, 61%–80%, and more than 80% of biofilm disruption after treatment with N. pogonosperma AgNP, respectively. Green synthesis of silver nanoparticles represent a promising strategy to counteract antimicrobial resistance. The AgNPs investigated in this study demonstrated significant potential in inhibiting biofilm formation and reducing bap gene expression in strong biofilm‐producing clinical isolates of A. baumannii . Further research is warranted to elucidate the underlying mechanisms and optimize the clinical application of these nanoparticles.


  • Open Access

    Therapeutic effects of nurse-led telephone follow-up on depression, anxiety, and stress in cardiovascular disease patients: a randomized clinical trial

    by Hossein Mohsenipouya, Maryam Mahtabi, Fateme Yagoubi, Abolfazl Hosseinnataj, Raha Jafari Ghaleh, Taís Carpes Lanes

    Background: Depression and anxiety are common among patients with cardiovascular disease (CVD) and are associated with poorer clinical outcomes, including increased complications and recurrent events. Nurse-led telephone follow-up after discharge has shown benefits in patient support and symptom management; however, its impact on psychological outcomes remains unclear. Therefore, this study aimed to evaluate the effects of a nurse-led telephone follow-up program on depression, anxiety, and stress levels in patients with cardiovascular disease. Methods: An experimental study was conducted with 60 randomly selected patients from the Coronary Care Unit (CCU) department of a hospital in Iran, who were divided into two groups: an intervention group and a control group. The educational intervention was administered within two weeks after discharge. Data were collected via the Depression Anxiety Stress Scale (DASS-21). Descriptive analysis, Mann-Whitney and Wilcoxon tests, Generalized Estimating Equations (GEE) regression, and Spearman’s correlation were used for data analysis. Results: The mean age of the patients was 57.43 ± 15.33 years. No significant differences were observed between the intervention and control groups regarding depression, anxiety, or stress scores (p>0.05). However, depression and anxiety scores decreased over time in both groups, with mean reductions of 1.53 and 1.18 points, respectively. Furthermore, an increase in patients’ ejection fraction (EF) was associated with a 0.1-point decrease in both depression and anxiety levels. No significant association was found between stress and the studied variables. Conclusions: Depression and anxiety decreased over time in patients with cardiovascular disease. However, no significant differences were found between the intervention and control groups. Improved cardiac function (ejection fraction) was associated with lower depression and anxiety, highlighting the importance of integrating psychological and clinical care. Further studies with larger samples and longer follow-up are recommended.

  • Investigating and Comparing the Effect of Articaine with Epinephrine 1:200000 in Type 2 Diabetic and Non-Diabetic Patients: A Clinical Trial

    by Mehdi Taghian, Abolfazl Hosseinnataj, Behrad Yadolah, Amir Hossein Akbari, Marzieh Movahedi, Leyli Sadri

    Introduction: Diabetes is highly prevalent in modern society. There are many controversies regarding the use of epinephrine in type 2 diabetic patients. This study aimed to examine and contrast the effects of articaine with epinephrine 1:200,000 in type 2 diabetic and non-diabetic patients referred to the Toubi Dental Clinic in Sari City. Methods: This clinical trial involved two parallel groups. 30 patients with diabetes (whose diabetes has been confirmed by an internist) and 30 systemically healthy patients were selected. The baseline state was used to measure the blood sugar levels in both groups. Then, blood sugar concentration was measured on two occasions, one after 5 minutes of 2 doses of articaine injection with epinephrine 1:200000, and the other after 15 minutes of injection. Mann-Whitney, Chi-square, and GEE non-parametric tests were used. Results: In each of the three instances, the average blood glucose level in the diabetic group was noticeably greater than that in the non-diabetic group. The average blood glucose at 15 minutes was significantly different from that at zero time, but the scale at 5 minutes did not have a substantial difference with zero time. Conclusion: Despite a considerable increase in blood glucose levels in diabetic patients 15 minutes after injection, the administration of two articaine capsules with epinephrine 1:200,000 remained deemed safe.

  • Thirty-year trends in the prevalence and incidence of multiple sclerosis (MS) in Mazandaran Province: Application of advanced statistical methods

    by Roya Nikbakht, Seyed Mohammad Baghbanian, Sharaeh Eskandarieh, Roja Nikaeen, Mohammadali Sahraian, Abolfazl Hosseinnataj

  • Open Access

    Effect of Leukocyte‐Platelet‐Rich Fibrin on Peri‐Implant Keratinized Mucosal Width and Mucosal Thickness Following Immediate Implant Placement: A Randomized Clinical Trial

    by Najmehsadat Valedsaravi, Mehrshad Ahmadi Dizgah, Amirhossein Moaddabi, Abolfazl Hosseinnataj

    Background: Adequate keratinized peri‐implant soft tissue supports plaque control, patient comfort, and long‐term tissue stability. This study evaluated whether application of a leukocyte‐platelet‐rich fibrin (L‐PRF) plug during immediate implant placement improves keratinized mucosal width (KMW) and peri‐implant mucosal thickness (PMT). Materials and Methods: In this parallel‐group randomized clinical trial, 60 systemically healthy patients requiring extraction and immediate implant placement were allocated to an L‐PRF group or a control group. The primary outcome was KMW at final follow‐up, whereas PMT at final follow‐up was considered a secondary clinical outcome. Both outcomes were analyzed using baseline‐adjusted ANCOVA. Results: All randomized participants completed the study. At baseline, PMT did not differ significantly between groups ( p = 0.505), whereas KMW was greater in the L‐PRF group ( p = 0.019). At the final follow‐up, both KMW and PMT increased significantly in both groups ( p < 0.001). The L‐PRF group demonstrated greater PMT and KMW at the final follow‐up than the control group ( p < 0.001 for both comparisons). After adjustment, group allocation remained a significant predictor of both PMT ( p < 0.001) and KMW ( p < 0.001). No adverse events were reported. Conclusion: In this trial, application of an L‐PRF plug during immediate implant placement was associated with greater KMW and PMT at final follow‐up than standard surgical closure alone. These findings should be interpreted with caution given the baseline KMW imbalance and the lack of consistently recorded surgical and site‐related variables. Trial Registration: Iranian Registry of Clinical Trials: IRCT20221228056958N2

  • Open Access

    Antifungal efficacy of caffeic acid and nano-caffeic acid particles against candidiasis: an in vitro study

    by Maede Salehi, Iman Haghani, Majid Saeedi, Katayoun Morteza-Semnani, Reza Negarandeh, Abolfazl Hosseinnataj, Ali Jafari, Anahita Lotfizadeh, Anahita Rafiei, Tahereh Molania

    Candidiasis is the most common oral fungal infection. Several medications have been introduced to manage this infection. This study investigated the antifungal effect of caffeic acid and nano-caffeic acid. The size and particle dispersion index (PDI) of caffeic acid-containing niosome vesicles were measured after their production. The zeta potential was measured using a Zetasizer Nano ZS, and the amount of nano-caffeic acid released from the vesicles was measured. Candida isolates were cultured in Malt Extract Agar medium. Nystatin, fluconazole, caffeic acid and nano-caffeic acid were studied according to the Clinical and Laboratory Standards Institute (CLSI) protocol (M27-A3/S4), a broth microdilution test was performed, and the minimum inhibitory concentration (MIC) was determined. The data were analyzed using the Mann‒Whitney and Kruskal‒Wallis tests. The optimal formulation had 100 mg Tween 60, 100 mg Span 60, 200 mg cholesterol, a size of 271.83 ± 3.11 nm, a PDI of 0.21 ± 0.02, a zeta potential of 5.58 ± 0.47 mV and an encapsulation efficiency (EE%) of 42.34 ± 4.34%. The size, absolute zeta potential and EE% increased significantly with increasing cholesterol content from zero to 200 mg (P < 0.05). Caffeic acid, nano-caffeic acid, carrier, fluconazole and nystatin had the lowest to highest antifungal activity, respectively. According to the MIC50 and MIC90 values, nystatin, fluconazole, carrier, nano-caffeic acid and caffeic acid had the highest to lowest inhibitory efficiency against Candida species, respectively.